NR4A1 and breast cancer: In previous studies on breast cancer patients, although volumetric parameters of [18F]FDG PET/CT cannot be used to differentiate hormone receptor status of cancer, TLG was significantly associated with aggressive tumor features and the presence of systemic metastasis [11–13].